KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Total Liabilities (2016 - 2025)

Amgen (AMGN) has 17 years of Total Liabilities data on record, last reported at $81.9 billion in Q4 2025.

  • For Q4 2025, Total Liabilities fell 4.69% year-over-year to $81.9 billion; the TTM value through Dec 2025 reached $81.9 billion, down 4.69%, while the annual FY2025 figure was $81.9 billion, 4.69% down from the prior year.
  • Total Liabilities reached $81.9 billion in Q4 2025 per AMGN's latest filing, up from $80.5 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $90.9 billion in Q4 2023 and bottomed at $51.5 billion in Q2 2021.
  • Average Total Liabilities over 5 years is $73.1 billion, with a median of $81.2 billion recorded in 2025.
  • Peak YoY movement for Total Liabilities: soared 47.94% in 2023, then fell 5.46% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $54.5 billion in 2021, then grew by 12.84% to $61.5 billion in 2022, then skyrocketed by 47.94% to $90.9 billion in 2023, then decreased by 5.46% to $86.0 billion in 2024, then fell by 4.69% to $81.9 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $81.9 billion in Q4 2025, $80.5 billion in Q3 2025, and $80.5 billion in Q2 2025.